tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Chad Mabry, 33 are a BUY (97.06%), 1 are a HOLD (2.94%).
Analyst Chad Mabry, carries an average stock price target met ratio of 42.59% that have a potential upside of 17.91% achieved within 357 days. Previously, Chad Mabry worked at MLV.
Chad Mabry’s has documented 69 price targets and ratings displayed on 9 stocks. The coverage was on Energy, Healthcare sectors.
Most recent stock forecast was given on ALT, Altimmune at 07-Sep-2021.
Analyst best performing recommendations are on ESTE (EARTHSTONE ENERGY).
The best stock recommendation documented was for ESTE (EARTHSTONE ENERGY) at 5/11/2016. The price target of $15 was fulfilled within 14 days with a profit of $3.43 (29.65%) receiving and performance score of 21.18.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$38
$2.24 (6.26%)
$40
1 years 1 months 25 days ago
(26-Feb-2024)
1/11 (9.09%)
$7.17 (23.26%)
7
Hold
$32
$-3.76 (-10.51%)
$44
1 years 2 months 28 days ago
(23-Jan-2024)
1/10 (10%)
$0.42 (1.33%)
1
Buy
$45
$9.24 (25.84%)
$51
1 years 3 months 12 days ago
(08-Jan-2024)
6/21 (28.57%)
$10.47 (30.32%)
28
Hold
$40
$4.24 (11.86%)
$41
1 years 4 months 22 days ago
(29-Nov-2023)
1/4 (25%)
$8.43 (26.70%)
45
$40
$4.24 (11.86%)
$41
1 years 4 months 22 days ago
(29-Nov-2023)
5/14 (35.71%)
$8.43 (26.70%)
30
What Year was the first public recommendation made by Chad Mabry?
